Search results for "Disc"

showing 10 items of 19256 documents

Role of neurophysiology in the clinical practice of primary pediatric headaches

2007

The role of electrophysiological studies in pediatric headaches is controversial. In childhood headaches, neurophysiological examinations are of interest for potential clinical use because they are noninvasive and are scarcely influenced by environmental factors or drug use. Electrophysiological studies in childhood headache principally explored the role of electroencephalographic (EEG) evaluations in migraine, while less evidence has been reported about other neurophysiological techniques, such as evoked potentials, event-related potentials, and, less often, transcranial magnetic stimulation. In this brief review, we point out our attention to the aid of neurophysiological methods in the c…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentElectroencephalographyNeurophysiologymedicine.diseasePharmacological treatmentClinical PracticeTranscranial magnetic stimulationMigraineClinical diagnosisDrug DiscoverymedicinePhysical therapyHeadachesmedicine.symptomIntensive care medicinebusinessDrug Development Research
researchProduct

Functional MRI and motor behavioral changes obtained with constraint-induced movement therapy in chronic stroke

2011

Background:  The clinical benefits of intensive stroke rehabilitation vary individually. We used multimodal functional imaging to assess the relationship of clinical gain and imaging changes in patients with chronic stroke whose voluntary motor control improved after constraint-induced movement therapy (CIMT). Methods:  Eleven patients (37.6 ± 36.8 months from stroke) were studied by functional MRI (fMRI), transcranial magnetic stimulation (TMS), and behavioral assessment of hand motor control (Wolf Motor Function Test) before and after 2 weeks of CIMT. Individual and group-level changes in imaging and behavioral parameters were investigated. Results:  Increase in fMRI activation in the sen…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentMotor controlMagnetic resonance imagingmedicine.diseasebehavioral disciplines and activitiesBrain mappingConstraint-induced movement therapyFunctional imagingTranscranial magnetic stimulationPhysical medicine and rehabilitationNeurologyLateralitymedicineNeurology (clinical)businessStrokepsychological phenomena and processesEuropean Journal of Neurology
researchProduct

IL-1β-converting enzyme (caspase-1) in intestinal inflammation

2001

IL-1β-converting enzyme (ICE; caspase-1) is the intracellular protease that cleaves the precursors of IL-1β and IL-18 into active cytokines. In the present study, the effect of ICE deficiency was evaluated during experimental colitis in mice. In acute dextran sulfate sodium-induced colitis, ICE-deficient (ICE KO) mice exhibited a greater than 50% decrease of the clinical scores weight loss, diarrhea, rectal bleeding, and colon length, whereas daily treatment with IL-1 receptor antagonist revealed a modest reduction in colitis severity. To further characterize the function of ICE and its role in intestinal inflammation, chronic colitis was induced over a 30-day time period. During this chron…

medicine.medical_specialtymedicine.drug_classCaspase 1BiologyProinflammatory cytokineMiceAntigens CDInternal medicinemedicineAnimalsColitisMice KnockoutMultidisciplinaryCaspase 1Interleukin-18InterleukinBiological SciencesColitismedicine.diseaseReceptor antagonistEndocrinologyImmunologyInterleukin 18Inflammation MediatorsCell activationIntracellularInterleukin-1Proceedings of the National Academy of Sciences
researchProduct

Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor

2002

(-)-(3aS,8aS,1S)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol-2′-ethylphenylcarbamate N-oxide hydrochloride (CHF2819) is a novel, orally active acetylcholinesterase inhibitor (AChEI) for Alzheimer's disease (AD). CHF2819 appears as a selective inhibitor of AChE, being 115 times more potent against this enzyme than butyrylcholinesterase (BuChE). Moreover, CHF2819 appears more selective for inhibiting central (brain) than peripheral (heart) AChE. In vivo studies show that CHF2819 significantly increases acetylcholine (ACh) levels in young adult rat hippocampus in a dose-dependent manner. Moreover, aged animals exhibit a marked increase in hippocampal concentrations of this…

medicine.medical_specialtymedicine.drug_classGlutamate receptorBiologyAcetylcholinesterasechemistry.chemical_compoundEndocrinologychemistryAcetylcholinesterase inhibitorDopamineEnzyme inhibitorInternal medicineDrug Discoverymedicinebiology.proteinNeurotransmitterAcetylcholineButyrylcholinesterasemedicine.drugDrug Development Research
researchProduct

Protrhombotic Effects of Contraceptives

2010

The use of oral contraceptives first became widespread some 40 years ago, and reports of an excess risk of cardiovascular disease among women who used these agents soon followed. Few drugs have been the object of such intensive epidemiological research, the outcome of which has provided clinicians with detailed information about risks not only of specific thrombotic diseases but also important non-contraceptive benefits from the pill. Recently, oral contraceptives have been classified by some according to "generation" (first, second, third, and most recently, fourth generation): first-generation formulations containing lynestrenol or norethindrone, second-generation formulations containing …

medicine.medical_specialtymedicine.drug_classLipid Metabolism DisordersMyocardial InfarctionPhysiologyGestodeneRisk AssessmentRisk FactorsDesogestrelInternal medicineDrug DiscoverymedicineHumansLevonorgestrelGlucose Metabolism DisordersVenous ThrombosisPharmacologyHemostasisbusiness.industryModels CardiovascularAtherosclerosisLipid MetabolismNorgestimateSettore MED/11 - Malattie Dell'Apparato CardiovascolareLynestrenolEndocrinologyEstrogenPillHypertensionFemaleRisk assessmentbusinessTrhombosis contraceptivesContraceptives Oralmedicine.drugCurrent Pharmaceutical Design
researchProduct

Mania associated with antidepressant treatment: comprehensive meta-analytic review

2009

Tondo L, Vazquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Objective:  To review available data pertaining to risk of mania–hypomania among bipolar (BPD) and major depressive disorder (MDD) patients with vs. without exposure to antidepressant drugs (ADs) and consider effects of mood stabilizers. Method:  Computerized searching yielded 73 reports (109 trials, 114 521 adult patients); 35 were suitable for random effects meta-analysis, and multivariate-regression modeling included all available trials to test for effects of trial design, AD type, and mood-stabilizer use. Results:  The overall risk of mania with/without ADs averaged …

medicine.medical_specialtymedicine.drug_classMood stabilizermedicine.diseasebehavioral disciplines and activitiesPsychiatry and Mental healthMoodMeta-analysismental disordersmedicineMajor depressive disorderAntidepressantBipolar disorderRisk factormedicine.symptomPsychiatryPsychologyManiaActa Psychiatrica Scandinavica
researchProduct

The role of fibrate treatment in dyslipidemia: an overview.

2012

Dyslipidemia, and especially atherogenic dyslipidemia, a combination of small low-density lipoproteins cholesterol (LDL-C), decreased high-density lipoprotein cholesterol (HDL-C) and increased triglyceride (TG) concentrations, represents a major cardiovascular (CV) risk factor. Nuclear receptor peroxisome proliferator-activated receptors (PPARs) are involved in the regulation of lipid metabolism; PPAR ligands are used to treat dyslipidemias. Fibrates have a major impact on TG metabolism as well as on modulating LDL size and subclasses. Fibrates target atherogenic dyslipidemia by increasing plasma HDL-C concentrations and decreasing small dense LDL (sdLDL) particles and TGs, thus contributin…

medicine.medical_specialtymedicine.drug_classPeroxisome proliferator-activated receptorAdipokineFibratechemistry.chemical_compoundInternal medicineDrug DiscoverymedicineAnimalsHumansTriglyceridesDyslipidemiasHypolipidemic AgentsPharmacologychemistry.chemical_classificationTriglycerideCholesterolbusiness.industryFibric Acidsnutritional and metabolic diseasesLipid metabolismCholesterol LDLmedicine.diseaseFibrates dyslipidemia cardiovascular risk diabetes.EndocrinologychemistryCardiovascular Diseaseslipids (amino acids peptides and proteins)Metabolic syndromebusinessDyslipidemiaCurrent pharmaceutical design
researchProduct

Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure.

2021

This study aimed to evaluate whether glomerular filtration rate (eGFR) during admission modifies the predictive value of plasma amino-terminal pro-brain natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) in patients hospitalized for acute heart failure (AHF).We retrospectively evaluated 4595 patients consecutively discharged after admission for AHF at three tertiary-care hospitals from January 2008 through October 2019. To investigate the effect of kidney function on the association of NT-proBNP and CA125 with 1-year mortality (all-cause and cardiovascular mortality), we stratified patients according to four eGFR categories:30 mL•minAt 1-year follow-up, 748 of 4595 (16.3%)…

medicine.medical_specialtymedicine.drug_classRenal functionCardiorenal syndromeInternal medicineNatriuretic Peptide BrainInternal MedicineNatriuretic peptideMedicineHumansIn patientCardiovascular mortalityRetrospective StudiesHeart Failurebusiness.industryAfter dischargemedicine.diseasePrognosisPeptide FragmentsHeart failureCA-125 AntigenCardiologyRisk of deathbusinessBiomarkersGlomerular Filtration RateEuropean journal of internal medicine
researchProduct

Catechol-O-Methyltransferase Gene Polymorphism Is Associated with Skeletal Muscle Properties in Older Women Alone and Together with Physical Activity

2008

BackgroundMuscle strength declines on average by one percent annually from midlife on. In postmenopausal women this decrement coincides with a rapid decline in estrogen production. The genetics underlying the effects of estrogen on skeletal muscle remains unclear. In the present study, we examined whether polymorphisms within COMT and ESR1 are associated with muscle properties and assessed their interaction and their combined effects with physical activity.Methodology/principal findingsA cross-sectional data analysis was conducted with 434 63-76-year-old women from the population-based Finnish Twin Study on Aging. Body anthropometry, muscle cross-sectional area (mCSA), isometric hand grip a…

medicine.medical_specialtymedicine.drug_classScienceeducationPhysical activityWomen's Health/Menopause and Post-Reproductive Women's HealthCatechol O-Methyltransferase03 medical and health sciences0302 clinical medicinePolymorphism (computer science)Internal medicineHand strengthGenetics and Genomics/Population GeneticsMedicineHumansMuscle SkeletalExercise030304 developmental biologyAged0303 health sciencesMultidisciplinaryCatechol-O-methyl transferasePolymorphism Geneticbusiness.industryPhysiology/EndocrinologyQRSkeletal muscleESR1 and Skeletal MuscleMiddle Aged314 Health sciencesTwin studyCOMTEndocrinologymedicine.anatomical_structureEstrogenMedicineESR1 ja luurankolihasFemalePublic Health and Epidemiology/EpidemiologybusinessEstrogen receptor alpha030217 neurology & neurosurgeryResearch ArticlePLoS ONE
researchProduct

D-dimer testing after anticoagulant discontinuation to predict recurrent venous thromboembolism

2021

medicine.medical_specialtymedicine.drug_classbusiness.industry10031 Clinic for AngiologyAnticoagulantMEDLINEAnticoagulants610 Medicine & healthVenous ThromboembolismGastroenterologyDiscontinuationFibrin Fibrinogen Degradation ProductsRecurrenceRisk Factors2724 Internal MedicineInternal medicineD-dimerInternal MedicinemedicineHumansbusinessVenous thromboembolismEuropean Journal of Internal Medicine
researchProduct